NCT04951388 - A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents | Biotech Hunter

Enrollment

399

Participants

Timeline

Start Date

July 22, 2021

Primary Completion Date

October 25, 2021

Study Completion Date

March 21, 2022

Conditions

Covid19 Vaccine

Interventions

BIOLOGICAL

MVC-COV1901(S protein with adjuvant)

Approximately 330 participants will receive 2 doses of MVC-COV1901(S-2P protein with adjuvant) at Visit 2 (Day 1) and Visit 4 (Day 29) via intramuscular (IM) injection in the deltoid region

BIOLOGICAL

MVC-COV1901(Saline)

Approximately 55 participants will receive 2 doses of MVC-COV1901(Saline) at Visit 2 (Day 1) and Visit 4 (Day 29) via IM injection in the deltoid region

Trial Locations (5)

Unknown

Mackay Memorial Hospital Hsinchu, Hsinchu

Chang-Guang Memorial Hospital Lin-Kou, Taipei

MacKay Memorial Hospital, Taipei

National Taiwan University Hospital-HsinChu, Taipei

National Taiwan University Hosptial, Taipei